Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pemigatinib is a targeted therapy drug developed by Incyte in the United States,···【more】
Release date：2024-08-12Recommended：243
Venetoclax is a drug used to treat leukemias, specifically chronic lymphocytic l···【more】
Release date：2024-08-09Recommended：294
Venetoclax is a BCL-2 inhibitor that selectively binds to BCL-2 protein and inhi···【more】
Release date：2024-08-09Recommended：254
Pemigatinib is a potent and selective oral antineoplastic drug targeting the FGF···【more】
Release date：2024-08-09Recommended：203
Pemigatinib is a targeted drug for cholangiocarcinoma, which has been marketed i···【more】
Release date：2024-08-09Recommended：161
Venetoclax is a drug used to treat chronic lymphocytic leukemia (CLL) and certai···【more】
Release date：2024-08-09Recommended：271
Capmatinib is a targeted drug manufactured by Novartis for the treatment of pati···【more】
Release date：2024-08-09Recommended：267
Capmatinib, trade name Tabrecta. It is an oral MET inhibitor mainly used for the···【more】
Release date：2024-08-09Recommended：257
Capmatinib is an oral, selective, ATP-competitive c-Met kinase inhibitor that in···【more】
Release date：2024-08-09Recommended：284
Pemigatinib is a targeted drug that is mainly used to treat cholangiocarcinoma.H···【more】
Release date：2024-08-09Recommended：210
Capmatinib is a lung cancer drug that targets specific genetic mutations, especi···【more】
Release date：2024-08-09Recommended：263
Pemigatinibis a targeted drug for the treatment of cholangiocarcinoma and belong···【more】
Release date：2024-08-09Recommended：236
